Nasal Polyps Treatment Market 2027 By Treatment Type, Distribution Channel and Geopgraphy | The Insight Partners

Nasal Polyps Treatment Market to 2027 - Global Analysis and Forecasts by Treatment Type (Corticosteroids, Antibiotics, Leukotriene Inhibitors, Others ); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ) and Geopgraphy

Report Code: TIPRE00006436 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Nasal polyps refer to painless, soft and non-cancerous growth that occurs on the nasal sinuses and passages. The polyp hangs down from the nasal lining like a tear drop. The larger sized nasal polyps blocks nasal passages and can lead to breathing problems as well as lead to frequent infections and a lost sense of smell. The nasal polyps are found to be more common in adults and can be treated through medications and surgeries.

MARKET DYNAMICS

The nasal polyp treatment market is anticipated to grow in the forecast, owing to increasing innovations by key players and new entrants in the market to develop innovative treatment solutions, rising regulatory approvals by government bodies for nasal polyps and others. On the other hand, researchers investigating treatments for chronic rhinosinusitis that also helps to decrease the size of nasal polyps are also expected to provide an opportunistic scenario for the nasal polyp treatment market growth.

MARKET SCOPE

The "Global Nasal Polyp Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of nasal polyp treatment market with detailed market segmentation by treatment type, distribution channel, and geography. The global nasal polyp treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading nasal polyp treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global nasal polyp treatment market is segmented on the basis of treatment type and distribution channel. Based on treatment type, the market is segmented as corticosteroids, antibiotics, leukotriene inhibitors, and others. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global nasal polyp treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The nasal polyp treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting nasal polyp treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the nasal polyp treatment market in these regions.


MARKET PLAYERS


The reports cover key developments in the nasal polyp treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from nasal polyp treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for nasal polyp treatment market in the global market. Below mentioned is the list of few companies engaged in the nasal polyp treatment market.

The report also includes the profiles of key nasal polyp treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  OptiNose US, Inc.
  •  Regeneron Pharmaceuticals, Inc.
  •  Merck KGaA
  •  Pfizer, Inc.
  •  F. Hoffmann La-Roche, Ltd.
  •  Intersect ENT, Inc.
  •  GlaxoSmithKline plc
  •  Novartis
  •  Sanofi
  •  Taro Pharmaceutical Industries Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Nasal Polyps Treatment Market - By Treatment Type
1.3.2 Nasal Polyps Treatment Market - By Distribution Channel
1.3.3 Nasal Polyps Treatment Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. NASAL POLYPS TREATMENT MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. NASAL POLYPS TREATMENT MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. NASAL POLYPS TREATMENT MARKET - GLOBAL MARKET ANALYSIS

6.1. NASAL POLYPS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. NASAL POLYPS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. NASAL POLYPS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT TYPE

7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. CORTICOSTEROIDS
7.3.1. Overview
7.3.2. Corticosteroids Market Forecast and Analysis
7.4. ANTIBIOTICS
7.4.1. Overview
7.4.2. Antibiotics Market Forecast and Analysis
7.5. LEUKOTRIENE INHIBITORS
7.5.1. Overview
7.5.2. Leukotriene Inhibitors Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis

8. NASAL POLYPS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL

8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis

9. NASAL POLYPS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Nasal Polyps Treatment Market Overview
9.1.2 North America Nasal Polyps Treatment Market Forecasts and Analysis
9.1.3 North America Nasal Polyps Treatment Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Nasal Polyps Treatment Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Nasal Polyps Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Nasal Polyps Treatment Market
9.1.5.1.1 United States Nasal Polyps Treatment Market by Treatment Type
9.1.5.1.2 United States Nasal Polyps Treatment Market by Distribution Channel
9.1.5.2 Canada Nasal Polyps Treatment Market
9.1.5.2.1 Canada Nasal Polyps Treatment Market by Treatment Type
9.1.5.2.2 Canada Nasal Polyps Treatment Market by Distribution Channel
9.1.5.3 Mexico Nasal Polyps Treatment Market
9.1.5.3.1 Mexico Nasal Polyps Treatment Market by Treatment Type
9.1.5.3.2 Mexico Nasal Polyps Treatment Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Nasal Polyps Treatment Market Overview
9.2.2 Europe Nasal Polyps Treatment Market Forecasts and Analysis
9.2.3 Europe Nasal Polyps Treatment Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Nasal Polyps Treatment Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Nasal Polyps Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Nasal Polyps Treatment Market
9.2.5.1.1 Germany Nasal Polyps Treatment Market by Treatment Type
9.2.5.1.2 Germany Nasal Polyps Treatment Market by Distribution Channel
9.2.5.2 France Nasal Polyps Treatment Market
9.2.5.2.1 France Nasal Polyps Treatment Market by Treatment Type
9.2.5.2.2 France Nasal Polyps Treatment Market by Distribution Channel
9.2.5.3 Italy Nasal Polyps Treatment Market
9.2.5.3.1 Italy Nasal Polyps Treatment Market by Treatment Type
9.2.5.3.2 Italy Nasal Polyps Treatment Market by Distribution Channel
9.2.5.4 Spain Nasal Polyps Treatment Market
9.2.5.4.1 Spain Nasal Polyps Treatment Market by Treatment Type
9.2.5.4.2 Spain Nasal Polyps Treatment Market by Distribution Channel
9.2.5.5 United Kingdom Nasal Polyps Treatment Market
9.2.5.5.1 United Kingdom Nasal Polyps Treatment Market by Treatment Type
9.2.5.5.2 United Kingdom Nasal Polyps Treatment Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Nasal Polyps Treatment Market Overview
9.3.2 Asia-Pacific Nasal Polyps Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Nasal Polyps Treatment Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Nasal Polyps Treatment Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Nasal Polyps Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Nasal Polyps Treatment Market
9.3.5.1.1 Australia Nasal Polyps Treatment Market by Treatment Type
9.3.5.1.2 Australia Nasal Polyps Treatment Market by Distribution Channel
9.3.5.2 China Nasal Polyps Treatment Market
9.3.5.2.1 China Nasal Polyps Treatment Market by Treatment Type
9.3.5.2.2 China Nasal Polyps Treatment Market by Distribution Channel
9.3.5.3 India Nasal Polyps Treatment Market
9.3.5.3.1 India Nasal Polyps Treatment Market by Treatment Type
9.3.5.3.2 India Nasal Polyps Treatment Market by Distribution Channel
9.3.5.4 Japan Nasal Polyps Treatment Market
9.3.5.4.1 Japan Nasal Polyps Treatment Market by Treatment Type
9.3.5.4.2 Japan Nasal Polyps Treatment Market by Distribution Channel
9.3.5.5 South Korea Nasal Polyps Treatment Market
9.3.5.5.1 South Korea Nasal Polyps Treatment Market by Treatment Type
9.3.5.5.2 South Korea Nasal Polyps Treatment Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Nasal Polyps Treatment Market Overview
9.4.2 Middle East and Africa Nasal Polyps Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Nasal Polyps Treatment Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Nasal Polyps Treatment Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Nasal Polyps Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Nasal Polyps Treatment Market
9.4.5.1.1 South Africa Nasal Polyps Treatment Market by Treatment Type
9.4.5.1.2 South Africa Nasal Polyps Treatment Market by Distribution Channel
9.4.5.2 Saudi Arabia Nasal Polyps Treatment Market
9.4.5.2.1 Saudi Arabia Nasal Polyps Treatment Market by Treatment Type
9.4.5.2.2 Saudi Arabia Nasal Polyps Treatment Market by Distribution Channel
9.4.5.3 U.A.E Nasal Polyps Treatment Market
9.4.5.3.1 U.A.E Nasal Polyps Treatment Market by Treatment Type
9.4.5.3.2 U.A.E Nasal Polyps Treatment Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Nasal Polyps Treatment Market Overview
9.5.2 South and Central America Nasal Polyps Treatment Market Forecasts and Analysis
9.5.3 South and Central America Nasal Polyps Treatment Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Nasal Polyps Treatment Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Nasal Polyps Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Nasal Polyps Treatment Market
9.5.5.1.1 Brazil Nasal Polyps Treatment Market by Treatment Type
9.5.5.1.2 Brazil Nasal Polyps Treatment Market by Distribution Channel
9.5.5.2 Argentina Nasal Polyps Treatment Market
9.5.5.2.1 Argentina Nasal Polyps Treatment Market by Treatment Type
9.5.5.2.2 Argentina Nasal Polyps Treatment Market by Distribution Channel

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. NASAL POLYPS TREATMENT MARKET, KEY COMPANY PROFILES

11.1. OPTINOSE US, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. REGENERON PHARMACEUTICALS, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MERCK KGAA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. PFIZER, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. F. HOFFMANN LA-ROCHE, LTD.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. INTERSECT ENT, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLAXOSMITHKLINE PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVARTIS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. Sanofi
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TARO PHARMACEUTICAL INDUSTRIES LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. OptiNose US, Inc.
2. Regeneron Pharmaceuticals, Inc.
3. Merck KGaA
4. Pfizer, Inc.
5. F. Hoffmann La-Roche, Ltd.
6. Intersect ENT, Inc.
7. GlaxoSmithKline plc
8. Novartis
9. Sanofi
10. Taro Pharmaceutical Industries Ltd.